Fraction Dose Escalation of Split-course Hypofractionated Concurrent Chemoradiotherapy Following Induction Chemo-immunotherapy in Unresectable Locally Advanced Esophageal Squamous Carcinoma: a Phase I Study.

Condition:   Esophageal Squamous Cell Carcinoma Interventions:   Radiation: Split-course hypo-CCRT;   Drug: Induction chemo-immunotherapy;   Drug: Concurrent chemotherapy Sponsor:   Sun Yat-sen University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials